| 1 |
Chilay A, Mehra N, Misra M, Almeida F, Chadha K, Jatale R, Ramchandran S. ROLE OF FECAL CALPROTECTIN FOR ASSESSMENT OF INFLAMMATORY BOWEL DISEASE ACTIVITY, 4-YEAR STUDY DONE IN INDIAN REFERENCE LABORATORY. IJAR 2022. [DOI: 10.36106/ijar/4101226] [Reference Citation Analysis]
|
| 2 |
Laskowska AK, Wilczak A, Skowrońska W, Michel P, Melzig MF, Czerwińska ME. Fruits of Hippophaë rhamnoides in human leukocytes and Caco-2 cell monolayer models—A question about their preventive role in lipopolysaccharide leakage and cytokine secretion in endotoxemia. Front Pharmacol 2022;13:981874. [DOI: 10.3389/fphar.2022.981874] [Reference Citation Analysis]
|
| 3 |
Sung J, Alghoul Z, Long D, Yang C, Merlin D. Oral delivery of IL-22 mRNA-loaded lipid nanoparticles targeting the injured intestinal mucosa: A novel therapeutic solution to treat ulcerative colitis. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Irwandi RA, Kuswandani SO, Harden S, Marletta D, D'Aiuto F. Circulating inflammatory cell profiling and periodontitis: A systematic review and meta-analysis. J Leukoc Biol 2022. [PMID: 35199874 DOI: 10.1002/JLB.5RU1021-524R] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 5 |
Wang H, Zheng X, Liu B, Xia Y, Xin Z, Deng B, He L, Deng J, Ren W. Aspartate Metabolism Facilitates IL-1β Production in Inflammatory Macrophages. Front Immunol 2021;12:753092. [PMID: 34745126 DOI: 10.3389/fimmu.2021.753092] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 6 |
Moreira Lopes TC, Mosser DM, Gonçalves R. Macrophage polarization in intestinal inflammation and gut homeostasis. Inflamm Res 2020;69:1163-72. [PMID: 32886145 DOI: 10.1007/s00011-020-01398-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 7 |
Kitajima T, Okita Y, Kawamura M, Kondo S, Toiyama Y, Uchida K, Kusunoki M. The relationship between preoperative T helper cytokines in the ileal mucosa and the pathogenesis of pouchitis. BMC Gastroenterol 2020;20:277. [PMID: 32811425 DOI: 10.1186/s12876-020-01421-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Lim HJ, Bak SG, Lim HJ, Lee SW, Lee S, Ku SK, Park SI, Lee SJ, Rho MC. Acyclic Triterpenoid Isolated from Alpinia katsumadai Alleviates Formalin-Induced Chronic Mouse Paw Inflammation by Inhibiting the Phosphorylation of ERK and NF-κB. Molecules 2020;25:E3345. [PMID: 32717961 DOI: 10.3390/molecules25153345] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 9 |
Kim JM, Cheon JH. Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases. Intest Res 2020;18:249-64. [PMID: 32295331 DOI: 10.5217/ir.2019.00128] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 10 |
Krznarić Ž, Markoš P, Golubić Ćepulić B, Čuković-Čavka S, Domislović V, Bojanić I, Barišić A, Kekez D. LEUKOCYTAPHERESIS IN THE MANAGEMENT OF SEVERE STEROID-DEPENDENT ULCERATIVE COLITIS. Acta Clin Croat 2019;58:529-34. [PMID: 31969767 DOI: 10.20471/acc.2019.58.03.18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 11 |
Margraf A, Ley K, Zarbock A. Neutrophil Recruitment: From Model Systems to Tissue-Specific Patterns. Trends Immunol 2019;40:613-34. [PMID: 31175062 DOI: 10.1016/j.it.2019.04.010] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 12 |
Hedin CRH, Vavricka SR, Stagg AJ, Schoepfer A, Raine T, Puig L, Pleyer U, Navarini A, van der Meulen-de Jong AE, Maul J, Katsanos K, Kagramanova A, Greuter T, González-Lama Y, van Gaalen F, Ellul P, Burisch J, Bettenworth D, Becker MD, Bamias G, Rieder F. The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy. J Crohns Colitis 2019;13:541-54. [PMID: 30445584 DOI: 10.1093/ecco-jcc/jjy191] [Cited by in Crossref: 71] [Cited by in F6Publishing: 69] [Article Influence: 17.8] [Reference Citation Analysis]
|
| 13 |
Neethi Raj P, Shaji BV, Haritha V, Anie Y. Neutrophil secretion modulates neutrophil and monocyte functions during hyperglucose and/or hyperinsulin conditions in vitro. Journal of Cellular Immunotherapy 2018;4:65-70. [DOI: 10.1016/j.jocit.2018.02.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 14 |
Saniabadi AR, Tanaka T, Yamamoto T, Kruis W, Sacco R. Granulomonocytapheresis as a cell-dependent treatment option for patients with inflammatory bowel disease: Concepts and clinical features for better therapeutic outcomes. J Clin Apher. 2019;34:51-60. [PMID: 30407662 DOI: 10.1002/jca.21670] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 15 |
Liu Z, Li X, Zhang M, Huang X, Bai J, Pan Z, Lin X, Yu D, Zeng H, Wan R, Ye X. The role of Mean Platelet Volume/platelet count Ratio and Neutrophil to Lymphocyte Ratio on the risk of Febrile Seizure. Sci Rep 2018;8:15123. [PMID: 30310107 DOI: 10.1038/s41598-018-33373-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 16 |
Schreiber S, Nikolaus S, Waetzig GH, Rosenstiel P. Reply. Gastroenterology 2018;154:2275-6. [PMID: 29750908 DOI: 10.1053/j.gastro.2018.05.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 17 |
McCarville JL, Dong J, Caminero A, Bermudez-Brito M, Jury J, Murray JA, Duboux S, Steinmann M, Delley M, Tangyu M, Langella P, Mercenier A, Bergonzelli G, Verdu EF. A Commensal Bifidobacterium longum Strain Prevents Gluten-Related Immunopathology in Mice through Expression of a Serine Protease Inhibitor. Appl Environ Microbiol 2017;83:e01323-17. [PMID: 28778891 DOI: 10.1128/AEM.01323-17] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 18 |
Marques GF, Osterne VJ, Almeida LM, Oliveira MV, Brizeno LA, Pinto-junior VR, Santiago MQ, Neco AH, Mota MR, Souza LA, Nascimento KS, Pires AF, Cavada BS, Assreuy AM. Contribution of the carbohydrate-binding ability of Vatairea guianensis lectin to induce edematogenic activity. Biochimie 2017;140:58-65. [DOI: 10.1016/j.biochi.2017.06.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 19 |
Venkiteswaran N, Ellepola K, Seneviratne C, Lee Y, Puan K, Wong S. Host–Biofilm Interactions at Mucosal Surfaces and Implications in Human Health. Microbial Biofilms 2017. [DOI: 10.1201/9781315120119-10] [Reference Citation Analysis]
|
| 20 |
Gerçeker E, Yüceyar H, Kasap E, Demirci U, Ekti BC, Aydoğdu İ, Miskioğlu M. Treatment of inflammatory bowel disease by leukocytapheresis. Transfus Apher Sci 2017;56:421-6. [PMID: 28454883 DOI: 10.1016/j.transci.2017.03.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 21 |
Kanai T. Leukocytapheresis Therapy of Inflammatory Bowel Disease. Crohn's Disease and Ulcerative Colitis 2017. [DOI: 10.1007/978-3-319-33703-6_49] [Reference Citation Analysis]
|
| 22 |
Sodek J, Batista Da Silva AP, Zohar R. Osteopontin and Mucosal Protection. J Dent Res 2006;85:404-15. [DOI: 10.1177/154405910608500503] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 23 |
Aydemir Y, Pınar A, Hızal G, Demir H, Saltık Temizel İN, Özen H, Akbıyık F, Yüce A. Neutrophil volume distribution width as a new marker in detecting inflammatory bowel disease activation. Int Jnl Lab Hem 2017;39:51-7. [DOI: 10.1111/ijlh.12574] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 24 |
Nyuyki KD, Pittman QJ. Toward a better understanding of the central consequences of intestinal inflammation. Ann N Y Acad Sci 2015;1351:149-54. [PMID: 26378439 DOI: 10.1111/nyas.12935] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 25 |
Hashiguchi K, Takeshima F, Akazawa Y, Matsushima K, Minami H, Machida H, Yamaguchi N, Shiozawa K, Ohba K, Ohnita K, Ichikawa T, Isomoto H, Nakao K. Advantages of fecal lactoferrin measurement during granulocyte and monocyte adsorptive apheresis therapy in ulcerative colitis. Digestion 2015;91:208-17. [PMID: 25823500 DOI: 10.1159/000375301] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 26 |
Capoccia E, Cirillo C, Gigli S, Pesce M, D’alessandro A, Cuomo R, Sarnelli G, Steardo L, Esposito G. Enteric glia: A new player in inflammatory bowel diseases. Int J Immunopathol Pharmacol 2015;28:443-51. [DOI: 10.1177/0394632015599707] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 27 |
Hamers AA, van Dam L, Teixeira Duarte JM, Vos M, Marinković G, van Tiel CM, Meijer SL, van Stalborch AM, Huveneers S, Te Velde AA, de Jonge WJ, de Vries CJ. Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages. PLoS One 2015;10:e0133598. [PMID: 26241646 DOI: 10.1371/journal.pone.0133598] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 28 |
Broekman MM, Roelofs HM, Hoentjen F, Wiegertjes R, Stoel N, Joosten LA, de Jong DJ, Wanten GJ. LPS-Stimulated Whole Blood Cytokine Production Is Not Related to Disease Behavior in Patients with Quiescent Crohn's Disease. PLoS One 2015;10:e0133932. [PMID: 26208333 DOI: 10.1371/journal.pone.0133932] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 29 |
Osada T, Watanabe S. Current Treatment Options for Inflammatory Bowel Diseases and Future Perspectives. Juntendo Medical Journal 2015;61:588-596. [DOI: 10.14789/jmj.61.588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 30 |
Inman KS, Francis AA, Murray NR. Complex role for the immune system in initiation and progression of pancreatic cancer. World J Gastroenterol 2014; 20(32): 11160-11181 [PMID: 25170202 DOI: 10.3748/wjg.v20.i32.11160] [Cited by in CrossRef: 89] [Cited by in F6Publishing: 95] [Article Influence: 9.9] [Reference Citation Analysis]
|
| 31 |
Sarlos P, Kovesdi E, Magyari L, Banfai Z, Szabo A, Javorhazy A, Melegh B. Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature. World J Gastrointest Pathophysiol 2014; 5(3): 304-321 [PMID: 25133031 DOI: 10.4291/wjgp.v5.i3.304] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 32 |
Saniabadi AR, Tanaka T, Ohmori T, Sawada K, Yamamoto T, Hanai H. Treating inflammatory bowel disease by adsorptive leucocytapheresis: A desire to treat without drugs. World J Gastroenterol 2014; 20(29): 9699-9715 [PMID: 25110409 DOI: 10.3748/wjg.v20.i29.9699] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 33 |
Park S, Regmi SC, Park S, Lee EK, Chang J, Ku SK, Kim D, Kim J. Protective effect of 7-O-succinyl macrolactin A against intestinal inflammation is mediated through PI3-kinase/Akt/mTOR and NF-κB signaling pathways. European Journal of Pharmacology 2014;735:184-92. [DOI: 10.1016/j.ejphar.2014.04.024] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 34 |
Chargui A, El May MV. Autophagy mediates neutrophil responses to bacterial infection. APMIS 2014;122:1047-58. [PMID: 24735202 DOI: 10.1111/apm.12271] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 35 |
Leach ST, Day AS. S100 proteins in the pathogenesis and diagnosis of inflammatory bowel disease. Expert Review of Clinical Immunology 2014;2:471-80. [DOI: 10.1586/1744666x.2.3.471] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 36 |
Gulbransen BD, Brown IAM. Enteric Glial Cells: Implications in Gut Pathology. Pathological Potential of Neuroglia 2014. [DOI: 10.1007/978-1-4939-0974-2_21] [Reference Citation Analysis]
|
| 37 |
Wang S, Zhou T, Zhai JP, Wang LH, Chen J. Effects of modified Sanhuang decoction () enema on serum tumor necrosis factor-α and colonic mucosa interleukin-1β, interleukin-6 levels in ulcerative colitis rats. Chin J Integr Med. 2014;20:865-869. [PMID: 24126972 DOI: 10.1007/s11655-013-1538-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 38 |
Tanaka T, Sugiyama S, Goishi H, Kajihara T, Akagi M, Miura T. Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications. BMC Gastroenterol. 2013;13:130. [PMID: 23961883 DOI: 10.1186/1471-230x-13-130] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 39 |
Tanaka T, Sugiyama S, Goishi H, Kajihara T, Akagi M, Miura T. Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications. BMC Gastroenterol. 2013;13:130. [PMID: 23961883 DOI: 10.1016/s1873-9946(13)60351-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 40 |
Iida T, Ikeya K, Watanabe F, Abe J, Maruyama Y, Ohata A, Teruyuki S, Sugimoto K, Hanai H. Looking for endoscopic features of cytomegalovirus colitis: a study of 187 patients with active ulcerative colitis, positive and negative for cytomegalovirus. Inflamm Bowel Dis 2013;19:1156-63. [PMID: 23619714 DOI: 10.1097/MIB.0b013e31828075ce] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 41 |
Montbarbon M, Pichavant M, Langlois A, Erdual E, Maggiotto F, Neut C, Mallevaey T, Dharancy S, Dubuquoy L, Trottein F, Cortot A, Desreumaux P, Gosset P, Bertin B. Colonic inflammation in mice is improved by cigarette smoke through iNKT cells recruitment. PLoS One 2013;8:e62208. [PMID: 23638007 DOI: 10.1371/journal.pone.0062208] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 42 |
Cury DB, Mizsputen SJ, Versolato C, Miiji LO, Pereira E, Delboni MA, Schor N, Moss AC. Serum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitis. Cell Immunol 2013;282:66-70. [PMID: 23685388 DOI: 10.1016/j.cellimm.2013.04.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 43 |
Martire-Greco D, Rodriguez-Rodrigues N, Landoni VI, Rearte B, Isturiz MA, Fernández GC. Interleukin-10 controls human peripheral PMN activation triggered by lipopolysaccharide. Cytokine 2013;62:426-32. [PMID: 23602200 DOI: 10.1016/j.cyto.2013.03.025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 44 |
Toya Y, Chiba T, Mizutani T, Sato K, Kasugai S, Matsuda N, Orikasa S, Shibata S, Abiko Y, Akasaka R, Yokoyama N, Oana S, Hirota S, Endo M, Suzuki K. The effect of granulocyte and monocyte adsorptive apheresis on serum cytokine levels in patients with ulcerative colitis. Cytokine 2013;62:146-50. [PMID: 23465691 DOI: 10.1016/j.cyto.2013.01.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 45 |
Tominaga K, Nakano M, Hoshino M, Kanke K, Hiraishi H. Efficacy, safety and cost analyses in ulcerative colitis patients undergoing granulocyte and monocyte adsorption or receiving prednisolone. BMC Gastroenterol. 2013;13:41. [PMID: 23452668 DOI: 10.1186/1471-230x-13-41] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 46 |
Nakano R, Iwakiri R, Ikeda Y, Kishi T, Tsuruoka N, Shimoda R, Sakata Y, Yamaguchi K, Fujimoto K. Factors affecting short- and long-term effects of leukocyte removal therapy in active ulcerative colitis. J Gastroenterol Hepatol 2013;28:303-8. [PMID: 23339387 DOI: 10.1111/jgh.12049] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 47 |
Ikeda S, Takahashi H, Suga Y, Eto H, Etoh T, Okuma K, Takahashi K, Kanbara T, Seishima M, Morita A, Imai Y, Kanekura T. Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis. J Am Acad Dermatol 2013;68:609-17. [PMID: 23332516 DOI: 10.1016/j.jaad.2012.09.037] [Cited by in Crossref: 83] [Cited by in F6Publishing: 84] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 48 |
Hanai H, Iida T, Ikeya K, Abe J, Maruyama Y, Shimura T, Sugimoto K, Watanabe F. A new paradigm in ulcerative colitis: regulatory T cells are key factor which induces/exacerbates UC through an immune imbalance. Mol Immunol. 2013;54:173-180. [PMID: 23280396 DOI: 10.1016/j.molimm.2012.11.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 49 |
Ortiz-Masià D, Díez I, Calatayud S, Hernández C, Cosín-Roger J, Hinojosa J, Esplugues JV, Barrachina MD. Induction of CD36 and thrombospondin-1 in macrophages by hypoxia-inducible factor 1 and its relevance in the inflammatory process. PLoS One 2012;7:e48535. [PMID: 23119050 DOI: 10.1371/journal.pone.0048535] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 50 |
Yiu HH, Graham AL, Stengel RF. Dynamics of a cytokine storm. PLoS One 2012;7:e45027. [PMID: 23049677 DOI: 10.1371/journal.pone.0045027] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 51 |
Trottier MD, Irwin R, Li Y, McCabe LR, Fraker PJ. Enhanced production of early lineages of monocytic and granulocytic cells in mice with colitis. Proc Natl Acad Sci U S A 2012;109:16594-9. [PMID: 23012474 DOI: 10.1073/pnas.1213854109] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 52 |
Fournier BM, Parkos CA. The role of neutrophils during intestinal inflammation. Mucosal Immunol 2012;5:354-66. [PMID: 22491176 DOI: 10.1038/mi.2012.24] [Cited by in Crossref: 407] [Cited by in F6Publishing: 408] [Article Influence: 37.0] [Reference Citation Analysis]
|
| 53 |
Fukunaga K, Matsumoto T. Current status and future perspectives of leukocytapheresis for inflammatory bowel disease. J Gastroenterol Hepatol 2012;27:997-1003. [PMID: 22414250 DOI: 10.1111/j.1440-1746.2012.07119.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 54 |
Aherne CM, Collins CB, Masterson JC, Tizzano M, Boyle TA, Westrich JA, Parnes JA, Furuta GT, Rivera-Nieves J, Eltzschig HK. Neuronal guidance molecule netrin-1 attenuates inflammatory cell trafficking during acute experimental colitis. Gut 2012;61:695-705. [PMID: 21813473 DOI: 10.1136/gutjnl-2011-300012] [Cited by in Crossref: 91] [Cited by in F6Publishing: 98] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 55 |
Santos Rocha C, Lakhdari O, Blottière HM, Blugeon S, Sokol H, Bermúdez-Humarán LG, Azevedo V, Miyoshi A, Doré J, Langella P, Maguin E, van de Guchte M. Anti-inflammatory properties of dairy lactobacilli. Inflamm Bowel Dis 2012;18:657-66. [PMID: 21837773 DOI: 10.1002/ibd.21834] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 56 |
Park SY, Ku SK, Lee ES, Kim JA. 1,3-Diphenylpropenone ameliorates TNBS-induced rat colitis through suppression of NF-κB activation and IL-8 induction. Chem Biol Interact 2012;196:39-49. [PMID: 22410118 DOI: 10.1016/j.cbi.2012.02.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 57 |
Roberts-Thomson IC, Fon J, Uylaki W, Cummins AG, Barry S. Cells, cytokines and inflammatory bowel disease: a clinical perspective. Expert Rev Gastroenterol Hepatol 2011;5:703-16. [PMID: 22017698 DOI: 10.1586/egh.11.74] [Cited by in Crossref: 74] [Cited by in F6Publishing: 83] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 58 |
Canedo J, Lee SH, Pinto R, Murad-Regadas S, Rosen L, Wexner SD. Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates? Colorectal Dis 2011;13:1294-8. [PMID: 20969715 DOI: 10.1111/j.1463-1318.2010.02469.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 83] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 59 |
Kaneda K, Saitoh F, Shibusawa H, Maegawa H, Saniabadi AR, Kashiwagi N, Matsukawa A. Correlation of neutrophil and monocyte derived interleukin-1 receptor antagonist and interleukin-8 with colitis severity in the rabbit. Cytokine 2011;56:508-14. [DOI: 10.1016/j.cyto.2011.07.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 60 |
Zhu M, Xu X, Nie F, Tong J, Xiao S, Ran Z. The efficacy and safety of selective leukocytapheresis in the treatment of ulcerative colitis: a meta-analysis. Int J Colorectal Dis 2011;26:999-1007. [PMID: 21476027 DOI: 10.1007/s00384-011-1193-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 61 |
Maor I, Rainis T, Lanir A, Lavy A. Adenosine deaminase activity in patients with Crohn's disease: distinction between active and nonactive disease. Eur J Gastroenterol Hepatol 2011;23:598-602. [PMID: 21593678 DOI: 10.1097/MEG.0b013e328346e205] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 62 |
Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, Klunker S, Meyer N, O’Mahony L, Palomares O. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2011;127:701-721.e1-70. [PMID: 21377040 DOI: 10.1016/j.jaci.2010.11.050] [Cited by in Crossref: 499] [Cited by in F6Publishing: 533] [Article Influence: 41.6] [Reference Citation Analysis]
|
| 63 |
Kum WW, Lo BC, Yu HB, Finlay BB. Protective role of Akt2 in Salmonella enterica serovar typhimurium-induced gastroenterocolitis. Infect Immun 2011;79:2554-66. [PMID: 21555401 DOI: 10.1128/IAI.01235-10] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 64 |
Chen Y, Wu H, Winnall WR, Loveland KL, Makanji Y, Phillips DJ, Smith JA, Hedger MP. Tumour necrosis factor‐α stimulates human neutrophils to release preformed activin A. Immunol Cell Biol 2011;89:889-96. [DOI: 10.1038/icb.2011.12] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 65 |
Fukunaga K, Yokoyama Y, Kamikozuru K, Yoshida K, Kikuyama R, Nagase K, Nakamura S, Takei Y, Miwa H, Matsumoto T. Selective depletion of peripheral granulocyte/monocyte enhances the efficacy of scheduled maintenance infliximab in Crohn's disease. J Clin Apher. 2010;25:226-228. [PMID: 20544712 DOI: 10.1002/jca.20242] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 66 |
Hanai H, Takeda Y, Eberhardson M, Gruber R, Saniabadi AR, Winqvist O, Lofberg R. The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review. Clin Exp Immunol. 2011;163:50-58. [PMID: 21078086 DOI: 10.1111/j.1365-2249.2010.04279.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 72] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 67 |
Hanai H, Takeda Y, Eberhardson M, Gruber R, Saniabadi AR, Winqvist O, Lofberg R. The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review. Clin Exp Immunol 2011;163:50-8. [PMID: 21078086 DOI: 10.1111/j.1365-2249.2010.04279.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 68 |
Bresci G, Romano A, Mazzoni A, Scatena F, Altomare E, Capria A, Sacco R. Feasibility and safety of granulocytapheresis in Crohn's disease: a prospective cohort study. Gastroenterol Clin Biol 2010;34:682-6. [PMID: 21075574 DOI: 10.1016/j.gcb.2010.09.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 69 |
Tanaka T, Okanobu H, Kuga Y, Yoshifuku Y, Fujino H, Miwata T, Moriya T, Nishida T, Oya T. Clinical and endoscopic features of responders and non-responders to adsorptive leucocytapheresis: a report based on 120 patients with active ulcerative colitis. Gastroenterol Clin Biol. 2010;34:687-695. [PMID: 20934287 DOI: 10.1016/j.gcb.2010.08.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 70 |
Lavoie-Lamoureux A, Maghni K, Lavoie JP. Optimization of a procedure to accurately detect equine TNFα in serum samples. Vet Immunol Immunopathol 2010;138:118-23. [PMID: 20674987 DOI: 10.1016/j.vetimm.2010.06.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 71 |
Lindberg A, Eberhardson M, Karlsson M, Karlén P. Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease. BMC Gastroenterol. 2010;10:73. [PMID: 20604939 DOI: 10.1186/1471-230x-10-73] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 72 |
Kum WW, Lo BC, Deng W, Ziltener HJ, Finlay BB. Impaired innate immune response and enhanced pathology during Citrobacter rodentium infection in mice lacking functional P-selectin. Cell Microbiol 2010;12:1250-71. [PMID: 20345490 DOI: 10.1111/j.1462-5822.2010.01466.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 73 |
Melmed GY, Targan SR. Future biologic targets for IBD: potentials and pitfalls. Nat Rev Gastroenterol Hepatol 2010;7:110-7. [PMID: 20134493 DOI: 10.1038/nrgastro.2009.218] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 74 |
Sakuraba A, Motoya S, Watanabe K, Nishishita M, Kanke K, Matsui T, Suzuki Y, Oshima T, Kunisaki R, Matsumoto T, Hanai H, Fukunaga K, Yoshimura N, Chiba T, Funakoshi S, Aoyama N, Andoh A, Nakase H, Mizuta Y, Suzuki R, Akamatsu T, Iizuka M, Ashida T, Hibi T. An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment. Am J Gastroenterol 2009;104:2990-5. [PMID: 19724269 DOI: 10.1038/ajg.2009.453] [Cited by in Crossref: 102] [Cited by in F6Publishing: 107] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 75 |
Rosenstiel P, Sina C, Franke A, Schreiber S. Towards a molecular risk map--recent advances on the etiology of inflammatory bowel disease. Semin Immunol 2009;21:334-45. [PMID: 19926490 DOI: 10.1016/j.smim.2009.10.001] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 76 |
Sina C, Gavrilova O, Förster M, Till A, Derer S, Hildebrand F, Raabe B, Chalaris A, Scheller J, Rehmann A, Franke A, Ott S, Häsler R, Nikolaus S, Fölsch UR, Rose-John S, Jiang HP, Li J, Schreiber S, Rosenstiel P. G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J Immunol 2009;183:7514-22. [PMID: 19917676 DOI: 10.4049/jimmunol.0900063] [Cited by in Crossref: 255] [Cited by in F6Publishing: 270] [Article Influence: 18.2] [Reference Citation Analysis]
|
| 77 |
Helmy A, Abdulla M, Kagevi I, Al Kahtani K. Leukocyte apheresis in the management of ulcerative colitis. Saudi J Gastroenterol 2009;15:283-7. [PMID: 19794281 DOI: 10.4103/1319-3767.56093] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 78 |
Hibi T, Sameshima Y, Sekiguchi Y, Hisatome Y, Maruyama F, Moriwaki K, Shima C, Saniabadi AR, Matsumoto T. Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan. Dig Liver Dis 2009;41:570-7. [PMID: 19211314 DOI: 10.1016/j.dld.2008.11.020] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 79 |
Kanmura S, Uto H, Numata M, Hashimoto S, Moriuchi A, Fujita H, Oketani M, Ido A, Kodama M, Ohi H, Tsubouchi H. Human neutrophil peptides 1-3 are useful biomarkers in patients with active ulcerative colitis. Inflamm Bowel Dis 2009;15:909-17. [PMID: 19107772 DOI: 10.1002/ibd.20854] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 80 |
Kum WW, Lee S, Grassl GA, Bidshahri R, Hsu K, Ziltener HJ, Finlay BB. Lack of functional P-selectin ligand exacerbates Salmonella serovar typhimurium infection. J Immunol 2009;182:6550-61. [PMID: 19414810 DOI: 10.4049/jimmunol.0802536] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 81 |
Yang GY, Taboada S, Liao J. Inflammatory bowel disease: a model of chronic inflammation-induced cancer. Methods Mol Biol. 2009;511:193-233. [PMID: 19347299 DOI: 10.1007/978-1-59745-447-6_9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 82 |
Fukunaga K, Nagase K, Kusaka T, Hida N, Ohda Y, Yoshida K, Tozawa K, Kamikozuru K, Iimuro M, Nakamura S, Miwa H, Matsumoto T. Cytapheresis in patients with severe ulcerative colitis after failure of intravenous corticosteroid: a long-term retrospective cohort study. Gut Liver 2009;3:41-7. [PMID: 20479900 DOI: 10.5009/gnl.2009.3.1.41] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 83 |
van Lierop PP, Samsom JN, Escher JC, Nieuwenhuis EE. Role of the innate immune system in the pathogenesis of inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2009;48:142-51. [PMID: 19179875 DOI: 10.1097/MPG.0b013e3181821964] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 84 |
Bresci G, Parisi G, Mazzoni A, Scatena F, Capria A. Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up. J Gastroenterol Hepatol 2008;23:1678-82. [PMID: 18823440 DOI: 10.1111/j.1440-1746.2008.05595.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 85 |
Nemoto Y, Kanai T, Tohda S, Totsuka T, Okamoto R, Tsuchiya K, Nakamura T, Sakamoto N, Fukuda T, Miura O, Yagita H, Watanabe M. Negative feedback regulation of colitogenic CD4+ T cells by increased granulopoiesis. Inflamm Bowel Dis 2008;14:1491-503. [PMID: 18623170 DOI: 10.1002/ibd.20531] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 86 |
Amati L, Passeri M, Selicato F, Mastronardi M, Penna A, Jirillo E, Covelli V. New Insights into the Biological and Clinical Significance of Fecal Calprotectin in Inflammatory Bowel Disease. Immunopharmacology and Immunotoxicology 2008;28:665-81. [DOI: 10.1080/08923970601067326] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 87 |
Bresci G. Granulocytapheresis in the treatment of patients with active ulcerative colitis. Expert Rev Gastroenterol Hepatol 2008;2:639-43. [PMID: 19072341 DOI: 10.1586/17474124.2.5.639] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 88 |
Brenmoehl J, Falk W, Göke M, Schölmerich J, Rogler G. Inflammation modulates fibronectin isoform expression in colonic lamina propria fibroblasts (CLPF). Int J Colorectal Dis 2008;23:947-55. [PMID: 18633626 DOI: 10.1007/s00384-008-0523-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 89 |
Pena-Rossi C, Schreiber S, Golubovic G, Mertz-Nielsen A, Panes J, Rachmilewitz D, Shieh MJ, Simanenkov VI, Stanton D, Graffner H. Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-beta-la in moderately active ulcerative colitis. Aliment Pharmacol Ther 2008;28:758-67. [PMID: 19145731 DOI: 10.1111/j.1365-2036.2008.03778.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 90 |
Tanaka T, Okanobu H, Yoshimi S, Murakami E, Kogame A, Imagawa H, Numata Y, Kuga Y, Moriya T, Ohya T, Kajiyama G. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients. Dig Liver Dis 2008;40:731-6. [PMID: 18387860 DOI: 10.1016/j.dld.2008.02.012] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 91 |
Maor I, Rainis T, Lanir A, Lavy A. Oxidative stress, inflammation and neutrophil superoxide release in patients with Crohn's disease: distinction between active and non-active disease. Dig Dis Sci 2008;53:2208-14. [PMID: 18253831 DOI: 10.1007/s10620-007-0141-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 92 |
Hanai H. Leucocytapheresis for inflammatory bowel disease in the era of biologic therapy. Eur J Gastroenterol Hepatol 2008;20:596-600. [PMID: 18679059 DOI: 10.1097/MEG.0b013e3282f5e9f3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 93 |
Baskol M, Baskol G, Koçer D, Ozbakir O, Yucesoy M. Advanced oxidation protein products: a novel marker of oxidative stress in ulcerative colitis. J Clin Gastroenterol 2008;42:687-91. [PMID: 18574392 DOI: 10.1097/MCG.0b013e318074f91f] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 94 |
Danese S, Angelucci E, Stefanelli T, Omodei P, Luigiano C, Finazzi S, Pagano N, Repici A, Vecchi M, Malesci A. Cytapheresis in inflammatory bowel diseases: current evidence and perspectives. Digestion 2008;77:96-107. [PMID: 18382085 DOI: 10.1159/000122473] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 95 |
Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Kageoka M, Ikeya K, Yamada M, Kikuyama M, Iwaoka Y, Hirayama K, Nagata S, Sato Y, Hosoda Y. Intensive granulocyte and monocyte adsorption versus intravenous prednisolone in patients with severe ulcerative colitis: an unblinded randomised multi-centre controlled study. Dig Liver Dis 2008;40:433-40. [PMID: 18296130 DOI: 10.1016/j.dld.2008.01.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 96 |
Hanai H, Iida T, Takeuchi K, Watanabe F, Yamada M, Kikuyama M, Maruyama Y, Iwaoka Y, Hirayama K, Nagata S, Takai K. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease. Am J Gastroenterol 2008;103:1210-6. [PMID: 18177452 DOI: 10.1111/j.1572-0241.2007.01714.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 97 |
Schulze HA, Häsler R, Mah N, Lu T, Nikolaus S, Costello CM, Schreiber S. From model cell line to in vivo gene expression: disease-related intestinal gene expression in IBD. Genes Immun 2008;9:240-8. [PMID: 18340362 DOI: 10.1038/gene.2008.11] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 98 |
Xiang JY, Ouyang Q, Li GD, Xiao NP. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis. World J Gastroenterol 2008; 14(1): 53-57 [PMID: 18176961 DOI: 10.3748/wjg.14.53] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 79] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 99 |
Matsumoto T, Fukunaga K, Kamikozuru K, Tozawa K, Yokoyama Y, Kusaka T, Onishi K, Miwa H, Nakamura S. Cytapheresis as a Non-Pharmacological Therapy for Inflammatory Bowel Disease. Transfus Med Hemother. 2008;35:18-23. [PMID: 21547106 DOI: 10.1159/000111763] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 100 |
Kühl AA, Kakirman H, Janotta M, Dreher S, Cremer P, Pawlowski NN, Loddenkemper C, Heimesaat MM, Grollich K, Zeitz M, Farkas S, Hoffmann JC. Aggravation of different types of experimental colitis by depletion or adhesion blockade of neutrophils. Gastroenterology 2007;133:1882-92. [PMID: 18054560 DOI: 10.1053/j.gastro.2007.08.073] [Cited by in Crossref: 130] [Cited by in F6Publishing: 132] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 101 |
Saniabadi AR, Hanai H, Fukunaga K, Sawada K, Shima C, Bjarnason I, Lofberg R. Therapeutic leukocytapheresis for inflammatory bowel disease. Transfus Apher Sci. 2007;37:191-200. [PMID: 17974479 DOI: 10.1016/j.transci.2007.08.003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 102 |
Yokoyama Y, Fukunaga K, Fukuda Y, Tozawa K, Kamikozuru K, Ohnishi K, Kusaka T, Kosaka T, Hida N, Ohda Y, Miwa H, Matsumoto T. Demonstration of low-regulatory CD25High+CD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis. Dig Dis Sci 2007;52:2725-31. [PMID: 17404876 DOI: 10.1007/s10620-006-9560-z] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 103 |
McGuire BB, Brannigan AE, O'Connell PR. Ileal pouch-anal anastomosis. Br J Surg. 2007;94:812-823. [PMID: 17571291 DOI: 10.1002/bjs.5866] [Cited by in Crossref: 81] [Cited by in F6Publishing: 84] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 104 |
Brown SJ, Mayer L. The immune response in inflammatory bowel disease. Am J Gastroenterol 2007;102:2058-69. [PMID: 17561966 DOI: 10.1111/j.1572-0241.2007.01343.x] [Cited by in Crossref: 158] [Cited by in F6Publishing: 162] [Article Influence: 9.9] [Reference Citation Analysis]
|
| 105 |
Ghia JE, Blennerhassett P, Collins SM. Vagus nerve integrity and experimental colitis. Am J Physiol Gastrointest Liver Physiol 2007;293:G560-7. [PMID: 17585014 DOI: 10.1152/ajpgi.00098.2007] [Cited by in Crossref: 70] [Cited by in F6Publishing: 72] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 106 |
Yamamoto T, Saniabadi AR, Maruyama Y, Umegae S, Matsumoto K. Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis. Dig Liver Dis 2007;39:626-33. [PMID: 17532273 DOI: 10.1016/j.dld.2007.04.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 107 |
Aoki H, Nakamura K, Yoshimatsu Y, Tsuda Y, Irie M, Fukuda K, Hosoe N, Takada N, Shirai K, Suzuki Y. Adacolumn selective leukocyte adsorption apheresis in patients with active ulcerative colitis: clinical efficacy, effects on plasma IL-8, and expression of Toll-like receptor 2 on granulocytes. Dig Dis Sci 2007;52:1427-33. [PMID: 17394078 DOI: 10.1007/s10620-006-9406-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 108 |
Rasmussen BS, Sollid J, Knudsen L, Christensen T, Toft E, Tønnesen E. The Release of Systemic Inflammatory Mediators Is Independent of Cardiopulmonary Bypass Temperature. Journal of Cardiothoracic and Vascular Anesthesia 2007;21:191-6. [DOI: 10.1053/j.jvca.2006.02.030] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 109 |
Wu HG, Liu HR, Tan LY, Gong YJ, Shi Y, Zhao TP, Yi Y, Yang Y. Electroacupuncture and moxibustion promote neutrophil apoptosis and improve ulcerative colitis in rats. Dig Dis Sci 2007;52:379-84. [PMID: 17211698 DOI: 10.1007/s10620-006-9561-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 110 |
Schreiber S, Keshavarzian A, Isaacs KL, Schollenberger J, Guzman JP, Orlandi C, Hanauer SB. A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis. Gastroenterology 2007;132:76-86. [PMID: 17241861 DOI: 10.1053/j.gastro.2006.11.029] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 111 |
Hanai H. Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis. World J Gastroenterol 2006; 12(47): 7568-7577 [PMID: 17171783 DOI: 10.3748/wjg.v12.i47.7568] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 112 |
Lee JY, Kim JS, Kim JM, Kim N, Jung HC, Song IS. Simvastatin inhibits NF-kappaB signaling in intestinal epithelial cells and ameliorates acute murine colitis. Int Immunopharmacol 2007;7:241-8. [PMID: 17178392 DOI: 10.1016/j.intimp.2006.10.013] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 113 |
Suzuki Y, Yoshimura N, Fukuda K, Shirai K, Saito Y, Saniabadi AR. A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis. Dig Dis Sci 2006;51:2031-8. [PMID: 17004123 DOI: 10.1007/s10620-006-9199-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 114 |
Muratov V, Lundahl J, Ulfgren AK, Elvin K, Fehrman I, Ahlborg N, Ost A, Hittel N, Saniabadi A, Löfberg R. Down-regulation of interferon-gamma parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease: a 12-month follow-up study. Int J Colorectal Dis 2006;21:493-504. [PMID: 16538495 DOI: 10.1007/s00384-005-0069-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 115 |
Yamamoto T, Saniabadi AR, Umegae S, Matsumoto K. Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: cytokine profiles and endoscopic findings. Inflamm Bowel Dis 2006;12:719-26. [PMID: 16917227 DOI: 10.1097/00054725-200608000-00008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 116 |
de Jong NS, Leach ST, Day AS. Fecal S100A12: a novel noninvasive marker in children with Crohn's disease. Inflamm Bowel Dis 2006;12:566-72. [PMID: 16804393 DOI: 10.1097/01.ibd.0000227626.72271.91] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 117 |
Hanai H, Iida T, Yamada M, Sato Y, Takeuchi K, Tanaka T, Kondo K, Kikuyama M, Maruyama Y, Iwaoka Y, Nakamura A, Hirayama K, Saniabadi AR, Watanabe F. Effects of adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis. World J Gastroenterol 2006; 12(21): 3393-3399 [PMID: 16733857 DOI: 10.3748/wjg.v12.i21.3393] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 40] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 118 |
D'Ovidio V, Aratari A, Viscido A, Marcheggiano A, Papi C, Capurso L, Caprilli R. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis. Dig Liver Dis 2006;38:389-94. [PMID: 16569521 DOI: 10.1016/j.dld.2005.12.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 119 |
Castro-Santos P, Suarez A, López-Rivas L, Mozo L, Gutierrez C. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency. Am J Gastroenterol 2006;101:1039-47. [PMID: 16573780 DOI: 10.1111/j.1572-0241.2006.00501.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 120 |
Kanai T, Hibi T, Watanabe M. The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease. Expert Opinion on Biological Therapy 2006;6:453-66. [DOI: 10.1517/14712598.6.5.453] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 121 |
Cabriada JL, Doménech E, Gomollón F, González-Carro P, González-Lara V, Hinojosa J, Jiménez-López CE, Nos P, Obrador A, Panès J, Saro C, Varea V, Lafuente R, Guilera M. [Consensus document on the use of granulocytapheresis in patients with inflammatory bowel disease]. Gastroenterol Hepatol 2006;29:85-92. [PMID: 16448611 DOI: 10.1157/13083905] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 122 |
Pineda AA. Developments in the apheresis procedure for the treatment of inflammatory bowel disease. Inflamm Bowel Dis 2006;12 Suppl 1:S10-4. [PMID: 16378005 DOI: 10.1097/01.mib.0000195386.19268.b3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 123 |
Sawada K, Kusugami K, Suzuki Y, Bamba T, Munakata A, Hibi T, Shimoyama T. Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment. Am J Gastroenterol 2005;100:1362-9. [PMID: 15929771 DOI: 10.1111/j.1572-0241.2005.41089.x] [Cited by in Crossref: 103] [Cited by in F6Publishing: 101] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 124 |
Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Kikuyama M, Tanaka T, Kondo K, Tanaka K, Takai K. Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis. World J Gastroenterol 2005; 11(20): 3085-3090 [PMID: 15918195 DOI: 10.3748/wjg.v11.i20.3085] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 125 |
Hanai H, Watanabe F, Yamada M, Sato Y, Takeuchi K, Iida T, Tozawa K, Tanaka T, Maruyama Y, Matsushita I, Iwaoka Y, Kikuch K, Saniabadi AR. Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis. Digestion 2004;70:36-44. [PMID: 15297776 DOI: 10.1159/000080079] [Cited by in Crossref: 104] [Cited by in F6Publishing: 111] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 126 |
Ludwiczek O, Vannier E, Borggraefe I, Kaser A, Siegmund B, Dinarello CA, Tilg H. Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease. Clin Exp Immunol. 2004;138:323-329. [PMID: 15498044 DOI: 10.1111/j.1365-2249.2004.02599.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 99] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 127 |
Lamine F, Eutamène H, Fioramonti J, Buéno L, Théodorou V. Colonic responses to Lactobacillus farciminis treatment in trinitrobenzene sulphonic acid-induced colitis in rats. Scand J Gastroenterol 2004;39:1250-8. [PMID: 15743003 DOI: 10.1080/00365520410007953] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 128 |
Kanke K, Nakano M, Hiraishi H, Terano A. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis. Dig Liver Dis 2004;36:811-7. [PMID: 15646427 DOI: 10.1016/j.dld.2004.08.004] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 129 |
Mori S, Nagashima M, Yoshida K, Yoshino K, Aoki M, Kawana S, Hirata I, Saniabadi A, Yoshino S. Granulocyte adsorptive apheresis for leg ulcers complicated by rheumatoid arthritis: a report on three successfully treated cases. Int J Dermatol 2004;43:732-5. [DOI: 10.1111/j.1365-4632.2004.01986.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 130 |
Hanai H, Takeuchi K, Iida T, Kashiwagi N, Saniabadi AR, Matsushita I, Sato Y, Kasuga N, Nakamura T. Relationship between fecal calprotectin, intestinal inflammation, and peripheral blood neutrophils in patients with active ulcerative colitis. Dig Dis Sci 2004;49:1438-43. [PMID: 15481316 DOI: 10.1023/b:ddas.0000042243.47279.87] [Cited by in Crossref: 86] [Cited by in F6Publishing: 77] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 131 |
Hanai H, Watanabe F, Yamada M, Sato Y, Takeuchi K, Iida T, Tozawa K, Tanaka T, Maruyama Y, Matsushita I, Iwaoka Y, Saniabadi A. Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis. Am J Gastroenterol 2004;99:1532-8. [PMID: 15307873 DOI: 10.1111/j.1572-0241.2004.30432.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 132 |
N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(7): 1631-1637 [DOI: 10.11569/wcjd.v12.i7.1631] [Reference Citation Analysis]
|
| 133 |
Agnholt J, Kelsen J, Brandsborg B, Jakobsen NO, Dahlerup JF. Increased production of granulocyte-macrophage colony-stimulating factor in Crohn's disease--a possible target for infliximab treatment. Eur J Gastroenterol Hepatol 2004;16:649-55. [PMID: 15201577 DOI: 10.1097/01.meg.0000108344.41221.8b] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 134 |
Suzuki Y, Yoshimura N, Saniabadi AR, Saito Y. Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci 2004;49:565-71. [PMID: 15185858 DOI: 10.1023/b:ddas.0000026299.43792.ae] [Cited by in Crossref: 117] [Cited by in F6Publishing: 97] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 135 |
Bojarski C, Weiske J, Schöneberg T, Schröder W, Mankertz J, Schulzke JD, Florian P, Fromm M, Tauber R, Huber O. The specific fates of tight junction proteins in apoptotic epithelial cells. J Cell Sci. 2004;117:2097-2107. [PMID: 15054114 DOI: 10.1242/jcs.01071] [Cited by in Crossref: 129] [Cited by in F6Publishing: 133] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 136 |
Zou K, Liu S, Xie X, Yi C. Clinical significance and assessment of cytokines in various stages of ulcerative colitis. J Tongji Med Univ 2001;21:308-9. [PMID: 12539555 DOI: 10.1007/BF02886564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 137 |
Pathmakanthan S, Li CK, Cowie J, Hawkey CJ. Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon. J Gastroenterol Hepatol 2004;19:166-73. [PMID: 14731126 DOI: 10.1111/j.1440-1746.2004.03181.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 138 |
Suzuki Y, Yoshimura N, Saitoh Y, Saniabadi AR. Granulocyte and monocyte adsorptive apheresis in a case with severe ulcerative colitis unresponsive to conventional medication. J Clin Apher 2003;18:40-2. [PMID: 12717793 DOI: 10.1002/jca.10048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 139 |
Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, Roth J. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 2003;52:847-53. [PMID: 12740341 DOI: 10.1136/gut.52.6.847] [Cited by in Crossref: 201] [Cited by in F6Publishing: 215] [Article Influence: 10.1] [Reference Citation Analysis]
|
| 140 |
Hiraishi K, Takeda Y, Shiobara N, Shibusawa H, Jimma F, Kashiwagi N, Saniabadi AR, Adachi M. Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis. Ther Apher Dial 2003;7:334-40. [PMID: 12924609 DOI: 10.1046/j.1526-0968.2003.00049.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 89] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 141 |
Hatzistilianou-sidiropoulou M, Nousia-arvanitakis S, Galli-tsinopoulou A, Agguridaki C, Xefteri M, Tsavdaridou V. Mediators of Inflammation in Children with Inflammatory Bowel Disease. Eur J Inflamm 2003;1:65-71. [DOI: 10.1177/1721727x0300100203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 142 |
Corredor J, Yan F, Shen CC, Tong W, John SK, Wilson G, Whitehead R, Polk DB. Tumor necrosis factor regulates intestinal epithelial cell migration by receptor-dependent mechanisms. Am J Physiol Cell Physiol 2003;284:C953-61. [PMID: 12466150 DOI: 10.1152/ajpcell.00309.2002] [Cited by in Crossref: 90] [Cited by in F6Publishing: 100] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 143 |
Saniabadi AR, Hanai H, Takeuchi K, Umemura K, Nakashima M, Adachi T, Shima C, Bjarnason I, Lofberg R. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial 2003;7:48-59. [PMID: 12921115 DOI: 10.1046/j.1526-0968.2003.00012.x] [Cited by in Crossref: 198] [Cited by in F6Publishing: 209] [Article Influence: 9.9] [Reference Citation Analysis]
|
| 144 |
O’neil D, Steidler L. Cytokines, Chemokines and Growth Factors in the Pathogenesis and Treatment of Inflammatory Bowel Disease. Advances in Experimental Medicine and Biology 2003. [DOI: 10.1007/978-1-4615-0171-8_15] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 145 |
Rogler G. Was bringen neue Zytokine und Antizytokine bei chronisch entzündlichen Darmerkrankungen? Chronisch entzündliche Darmerkrankungen 2003. [DOI: 10.1007/978-3-642-19025-4_15] [Reference Citation Analysis]
|
| 146 |
Hanai H, Watanabe F, Takeuchi K, Iida T, Yamada M, Iwaoka Y, Saniabadi A, Matsushita I, Sato Y, Tozawa K, Arai H, Furuta T, Sugimoto K, Bjarnason I. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol 2003;1:28-35. [PMID: 15017514 DOI: 10.1053/jcgh.2003.50005] [Cited by in Crossref: 160] [Cited by in F6Publishing: 162] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 147 |
Nagura H, Matsumoto T. Immunopathology of Inflammatory Bowel Disease and Roles of the Mucosal Immune System. Pathology Case Reviews 2002;7:247-253. [DOI: 10.1097/00132583-200211000-00002] [Reference Citation Analysis]
|
| 148 |
Waetzig GH, Seegert D, Rosenstiel P, Nikolaus S, Schreiber S. p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease. J Immunol 2002;168:5342-51. [PMID: 11994493 DOI: 10.4049/jimmunol.168.10.5342] [Cited by in Crossref: 297] [Cited by in F6Publishing: 311] [Article Influence: 14.1] [Reference Citation Analysis]
|
| 149 |
Xie H, Huff GR, Huff WE, Balog JM, Holt P, Rath NC. Identification of ovotransferrin as an acute phase protein in chickens. Poult Sci 2002;81:112-20. [PMID: 11885890 DOI: 10.1093/ps/81.1.112] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 150 |
Steidler L. In situ delivery of cytokines by genetically engineered Lactococcus lactis. Lactic Acid Bacteria: Genetics, Metabolism and Applications 2002. [DOI: 10.1007/978-94-017-2029-8_21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 151 |
Ji WS, Hu JL, Qiu JW, Pan BR, Peng DR, Shi BL, Zhou SJ, Wu KC, Fan DM. Relationship between genotype and phenotype of flagellin C in Salmonella. World J Gastroenterol 2001; 7(6): 864-867 [PMID: 11854918 DOI: 10.3748/wjg.v7.i6.864] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 152 |
Thomson AB, Keelan M, Thiesen A, Clandinin MT, Ropeleski M, Wild GE. Small bowel review: normal physiology part 2. Dig Dis Sci 2001;46:2588-607. [PMID: 11768248 DOI: 10.1023/a:1012746622735] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 153 |
Wallace JL, Ma L. Inflammatory mediators in gastrointestinal defense and injury. Exp Biol Med (Maywood) 2001;226:1003-15. [PMID: 11743136 DOI: 10.1177/153537020122601107] [Cited by in Crossref: 74] [Cited by in F6Publishing: 79] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 154 |
Xue ML, Zhu H, Willcox M, Wakefield D, Lloyd A, Thakur A. The role of IL-1beta in the regulation of IL-8 and IL-6 in human corneal epithelial cells during Pseudomonas aeruginosa colonization. Curr Eye Res 2001;23:406-14. [PMID: 12045890 DOI: 10.1076/ceyr.23.6.406.6969] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 155 |
Blandino IIP, Otaka M, Jin M, Komatsu K, Odashima M, Konishi N, Sato T, Kato S, Watanabe S. FR167653, a potent suppressant of interleukin-1 and tumor necrosis factor-alpha production, ameliorates colonic lesions in experimentally induced acute colitis1. J Gastroenterol Hepatol 2001;16:1105-1111. [DOI: 10.1046/j.1440-1746.2001.02584.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 156 |
Brix-Christensen V, Petersen TK, Ravn HB, Hjortdal VE, Andersen NT, Tønnesen E. Cardiopulmonary bypass elicits a pro- and anti-inflammatory cytokine response and impaired neutrophil chemotaxis in neonatal pigs. Acta Anaesthesiol Scand 2001;45:407-13. [PMID: 11300377 DOI: 10.1034/j.1399-6576.2001.045004407.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 157 |
Kühbacher T, Gionchetti P, Hampe J, Helwig U, Rosenstiel P, Campieri M, Buhr HJ, Schreiber S. Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis. Clin Exp Immunol 2001;123:395-401. [PMID: 11298125 DOI: 10.1046/j.1365-2249.2001.01455.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 158 |
Rühl A, Franzke S, Stremmel W. IL-1beta and IL-10 have dual effects on enteric glial cell proliferation. Neurogastroenterol Motil 2001;13:89-94. [PMID: 11169130 DOI: 10.1046/j.1365-2982.2001.00245.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 159 |
Schreiber S. Immunopathophysiology of inflammatory bowel disease. Immunological Aspects of Gastroenterology 2001. [DOI: 10.1007/978-94-010-0790-0_9] [Reference Citation Analysis]
|
| 160 |
Riffkin MC, Seow HF, Wood PR, Brown LE, Jackson DC, Scheerlinck JP. Trichostrongylus colubriformis extract upregulates TNF-alpha receptor expression and enhances TNF-alpha sensitivity of L929 cells. Immunol Cell Biol 2000;78:575-9. [PMID: 11114966 DOI: 10.1046/j.1440-1711.2000.00948.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 161 |
Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000;30:1604-10. [PMID: 11069570 DOI: 10.1046/j.1365-2222.2000.00943.x] [Cited by in Crossref: 622] [Cited by in F6Publishing: 645] [Article Influence: 27.0] [Reference Citation Analysis]
|
| 162 |
Bulois P, Tremaine WJ, Maunoury V, Gambiez L, Hafraoui S, Leteurtre L, Cortot A, Sandborn WJ, Colombel JF, Desreumaux P. Pouchitis is associated with mucosal imbalance between interleukin-8 and interleukin-10. Inflamm Bowel Dis 2000;6:157-64. [PMID: 10961587 DOI: 10.1097/00054725-200008000-00001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 163 |
Schottelius A, Wedel S, Weltrich R, Rohde W, Buttgereit F, Schreiber S, Lochs H. Higher expression of glucocorticoid receptor in peripheral mononuclear cells in inflammatory bowel disease. Am J Gastroenterol 2000;95:1994-9. [PMID: 10950048 DOI: 10.1111/j.1572-0241.2000.02188.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 164 |
Korzenik JR, Dieckgraefe BK. Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease. Dig Dis Sci 2000;45:1121-9. [PMID: 10877227 DOI: 10.1023/a:1005541700805] [Cited by in Crossref: 86] [Cited by in F6Publishing: 91] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 165 |
Oprins JC, Meijer HP, Groot JA. TNF-alpha potentiates the ion secretion induced by muscarinic receptor activation in HT29cl.19A cells. Am J Physiol Cell Physiol 2000;278:C463-72. [PMID: 10712234 DOI: 10.1152/ajpcell.2000.278.3.C463] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 166 |
Wieland E, Shipkova M, Schellhaas U, Schütz E, Niedmann PD, Armstrong VW, Oellerich M. Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects? Clin Biochem 2000;33:107-13. [PMID: 10751588 DOI: 10.1016/s0009-9120(99)00101-0] [Cited by in Crossref: 111] [Cited by in F6Publishing: 115] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 167 |
Schreiber S, Schottelius A. Chronisch entzündliche Darmerkrankungen. Springer Lehrbuch 2000. [DOI: 10.1007/978-3-642-57115-2_19] [Reference Citation Analysis]
|
| 168 |
Kim JM, Kim JS, Jung HC, Song IS, Kim CY. Apoptosis of human gastric epithelial cells via caspase-3 activation in response to Helicobacter pylori infection: possible involvement of neutrophils through tumor necrosis factor alpha and soluble Fas ligands. Scand J Gastroenterol 2000;35:40-8. [PMID: 10672833 DOI: 10.1080/003655200750024515] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 169 |
Isolauri E. Probiotics and gut inflammation. Curr Opin Gastroenterol 1999;15:534-7. [PMID: 17024003 DOI: 10.1097/00001574-199911000-00014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 170 |
Stallmach A, Wittig B, Giese T, Pfister K, Hoffmann JC, Bulfone-Paus S, Kunzendorf U, Meuer SC, Zeitz M. Protection of trinitrobenzene sulfonic acid-induced colitis by an interleukin 2-IgG2b fusion protein in mice. Gastroenterology 1999;117:866-76. [PMID: 10500069 DOI: 10.1016/s0016-5085(99)70345-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 171 |
Campos MM, Souza GE, Calixto JB. In vivo B1 kinin-receptor upregulation. Evidence for involvement of protein kinases and nuclear factor kappaB pathways. Br J Pharmacol 1999;127:1851-9. [PMID: 10482916 DOI: 10.1038/sj.bjp.0702715] [Cited by in Crossref: 73] [Cited by in F6Publishing: 73] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 172 |
Sher ME, Bank S, Greenberg R, Sardinha TC, Weissman S, Bailey B, Gilliland R, Wexner SD. The influence of cigarette smoking on cytokine levels in patients with inflammatory bowel disease. Inflamm Bowel Dis 1999;5:73-8. [PMID: 10338374 DOI: 10.1097/00054725-199905000-00001] [Cited by in Crossref: 59] [Cited by in F6Publishing: 66] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 173 |
Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Förster I, Akira S. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999;10:39-49. [PMID: 10023769 DOI: 10.1016/s1074-7613(00)80005-9] [Cited by in Crossref: 943] [Cited by in F6Publishing: 971] [Article Influence: 39.3] [Reference Citation Analysis]
|
